oleic acid and avasimibe

oleic acid has been researched along with avasimibe in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Adeli, K; Kulinski, A; Rudy, D; Taghibiglou, C; Van Iderstine, SC	1

Other Studies

2 other study(ies) available for oleic acid and avasimibe

Article	Year
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
Intracellular mechanisms mediating the inhibition of apoB-containing lipoprotein synthesis and secretion in HepG2 cells by avasimibe (CI-1011), a novel acyl-coenzyme A: cholesterol acyltransferase (ACAT) inhibitor. Biochemical pharmacology, 2002, Feb-01, Volume: 63, Issue:3 Topics: Acetamides; Acetates; Apolipoprotein B-100; Apolipoproteins B; Biological Transport; Cysteine Proteinase Inhibitors; Endoplasmic Reticulum; Enzyme Inhibitors; Golgi Apparatus; Humans; Leupeptins; Lipid Metabolism; Oleic Acid; Sterol O-Acyltransferase; Sulfonamides; Sulfonic Acids; Tumor Cells, Cultured	2002

Article

Year

Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.

Chemical research in toxicology, 2010, Volume: 23, Issue:1

Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010

Intracellular mechanisms mediating the inhibition of apoB-containing lipoprotein synthesis and secretion in HepG2 cells by avasimibe (CI-1011), a novel acyl-coenzyme A: cholesterol acyltransferase (ACAT) inhibitor.

Biochemical pharmacology, 2002, Feb-01, Volume: 63, Issue:3

Topics: Acetamides; Acetates; Apolipoprotein B-100; Apolipoproteins B; Biological Transport; Cysteine Proteinase Inhibitors; Endoplasmic Reticulum; Enzyme Inhibitors; Golgi Apparatus; Humans; Leupeptins; Lipid Metabolism; Oleic Acid; Sterol O-Acyltransferase; Sulfonamides; Sulfonic Acids; Tumor Cells, Cultured

2002